Targeted dosing to treat pediatric inflammatory bowel disease is challenging because dosing guidelines are based on data gathered from adult subjects of clinical trials. Patients’ families and health care organizations also incur high costs and must try to balance potential benefits against risks of ongoing monitoring.
AMA J Ethics. 2018;20(9):E841-848. doi:
10.1001/amajethics.2018.841.
Dr Jeff Sebo joins Ethics Talk to discuss his article, coauthored with Zoe Griffiths: "How Should We Improve How Medical and Veterinary Students Learn About Human and Nonhuman Animals?"